OXEZE TURBUHALER 6 MCG
FORMOTEROL FUMARATE DIHYDRATE : 6 MCG · DIN 02237225 · ASTRAZENECA CANADA INC
Health Canada status: MARKETED
What is OXEZE TURBUHALER?
OXEZE TURBUHALER 6 MCG contains FORMOTEROL FUMARATE DIHYDRATE : 6 MCG. It is listed in the Health Canada Drug Product Database under DIN 02237225, held by ASTRAZENECA CANADA INC, supplied as POWDER for INHALATION administration. Health Canada currently lists it as marketed, status dated 01-Jun-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is OXEZE TURBUHALER used for?
OXEZE TURBUHALER is indicated for the treatment of asthma only as add-on therapy to an inhaled corticosteroid, a long-term asthma control medication, in patients 6 years of age and older with reversible obstructive airways disease, including patients with symptoms of nocturnal asthma. It is also indicated for the acute prevention of exercise-induced bronchoconstriction in adults and children 6 years of age and older, when administered on an occasional, as-needed basis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02237225 |
|---|---|
| Brand name | OXEZE TURBUHALER |
| Generic / active ingredient | FORMOTEROL FUMARATE DIHYDRATE : 6 MCG |
| Manufacturer | ASTRAZENECA CANADA INC |
| Strength | 6 MCG |
| Dosage form | POWDER |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | R03AC13 FORMOTEROL |
| AHFS class | 12:12.08.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 01-Jun-2016 |
| Original market date | 1998-03-12 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code R03AC13 FORMOTEROL. 2 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| OXEZE TURBUHALER | 12 MCG | POWDER | ASTRAZENECA CANADA INC | MARKETED | DIN 02237224 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12 MCG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 02230898 |
Who else supplies FORMOTEROL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FORMOTEROL appears in 62 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.